Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerard Curley

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Trials|September 14, 2022
The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trialJohn Robert Sheehan, Padraig Calpin, Maeve Kernan, et al.
ATS Scholar|October 20, 2021
Supervision, Interprofessional Collaboration, and Patient Safety in Intensive Care Units during the COVID-19 PandemicMarije P Hennus, John Q Young, Martina Hennessy, et al.
Trials|May 13, 2022
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trialEllen Gorman, Manu Shankar-Hari, Phil Hopkins, et al.
Trials|June 5, 2020
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trialEllen Gorman, Manu Shankar-Hari, Phil Hopkins, et al.
Intensive Care Medicine Experimental|February 7, 2025
Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: the CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label studyDavid Cosgrave, Bairbre McNicholas, Ciara Hanley, et al.
Eclinicalmedicine|November 8, 2021
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trialEllen Gorman, Manu Shankar-Hari, Phil Hopkins, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2023
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical TrialEllen A Gorman, Jennifer Rynne, Hannah J Gardiner, et al.
Eclinicalmedicine|November 3, 2025
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studiesFrank M P van Haren, Sarah J Valle, Ary Serpa Neto, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Trials|September 14, 2022
The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trialJohn Robert Sheehan, Padraig Calpin, Maeve Kernan, et al.
ATS Scholar|October 20, 2021
Supervision, Interprofessional Collaboration, and Patient Safety in Intensive Care Units during the COVID-19 PandemicMarije P Hennus, John Q Young, Martina Hennessy, et al.
Trials|May 13, 2022
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trialEllen Gorman, Manu Shankar-Hari, Phil Hopkins, et al.
Trials|June 5, 2020
Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trialEllen Gorman, Manu Shankar-Hari, Phil Hopkins, et al.
Intensive Care Medicine Experimental|February 7, 2025
Can nebulised heparin reduce acute lung injury in patients with SARS‑CoV‑2 requiring advanced respiratory support in Ireland: the CHARTER‑Ireland phase Ib/IIa, randomised, parallel-group, open-label studyDavid Cosgrave, Bairbre McNicholas, Ciara Hanley, et al.
Eclinicalmedicine|November 8, 2021
Repair of acute respiratory distress syndrome by stromal cell administration (REALIST) trial: A phase 1 trialEllen Gorman, Manu Shankar-Hari, Phil Hopkins, et al.
American Journal of Respiratory and Critical Care Medicine|May 8, 2023
Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical TrialEllen A Gorman, Jennifer Rynne, Hannah J Gardiner, et al.
Eclinicalmedicine|November 3, 2025
Efficacy of inhaled nebulised unfractionated heparin to prevent intubation or death in hospitalised patients with COVID-19: an investigator-initiated international meta-trial of randomised clinical studiesFrank M P van Haren, Sarah J Valle, Ary Serpa Neto, et al.
Pageof 3